Oncosys Formulations Private Limited
About Oncosys Formulations Private Limited
Data last updated:
Oncosys Formulations Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 25 July 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24230UP2022PTC168179.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pooja Dwivedi and Ashish Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P 8/15 Bhadaini, Varanasi, Uttar Pradesh, India – 221005.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.83 Lakh, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹35,393 (net margin 4.5%) and EBITDA of ₹49,761 (EBITDA margin 6.4%).
Company details
Contact details
Oncosys Formulations Private Limited's registered office is in Varanasi, Uttar Pradesh.
- Registered AddressP 8/15 Bhadaini, Varanasi, Uttar Pradesh, India – 221005
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oncosys Formulations is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Oncosys Formulations Private Limited, buy the company report.
Financials of Oncosys Formulations Private Limited
FY 2025 filings availableOncosys Formulations Private Limited reported revenue of ₹7.83 Lakh (up 27% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 27% in the latest year. EBITDA rose 41% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹49,761 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹35,393 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 6.4% | ||
| Net Profit Margin | 4.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Oncosys Formulations Private Limited, buy the company report.
Board of directors of Oncosys Formulations Private Limited
Oncosys Formulations has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pooja Dwivedi Also directs: Pvrap LLP | Director | 25 Jul 2022 | 4 Years 3 Months | Current |
| Ashish Kumar Singh | Director | 25 Jul 2022 | 4 Years 3 Months | Current |
| Anup Kumar Singh | Director | 25 Jul 2022 | 4 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Oncosys Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oncosys Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Oncosys Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Oncosys Formulations Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Ashish Kumar Singh ceased to be Director on 16 Jan 2026.
Frequently asked questions
Oncosys Formulations is an active private limited company based in Varanasi, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 25 July 2022 (4+ years old) and is registered under CIN U24230UP2022PTC168179.
Oncosys Formulations has 3 current directors:
- Pooja Dwivedi - Director
- Ashish Kumar Singh - Director
- Anup Kumar Singh - Director
The latest financial statements of Oncosys Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Oncosys Formulations is U24230UP2022PTC168179. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oncosys Formulations was incorporated on 25 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Ashish Kumar Singh ceased to be Director on 16 Jan 2026. Anup Kumar Singh was appointed as Director on 25 Jul 2022. Ashish Kumar Singh was appointed as Director on 25 Jul 2022. Oncosys Formulations has 4 board changes on record in total.
The registered office of Oncosys Formulations is at P 815 Bhadaini, Varanasi, Uttar Pradesh, India – 221005.
Oncosys Formulations operates in the chemicals industry, in the manufacturing segment.
Oncosys Formulations can be reached at its registered office: P 815 Bhadaini, Varanasi, Uttar Pradesh, India – 221005.
Oncosys Formulations is registered under the jurisdiction of the Registrar of Companies (ROC), Uttar Pradesh.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
